Asia-Pacific Nuclear Medicine Diagnostics Market by SPECT (Technetium-99m, Iodine, Thallium-201 and others) and PET (Rubidium-82, Fluorine-18, and others)), by Application (cardiology, lymphoma, thyroid, neurology, oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Nuclear Medicine Diagnostics Market by SPECT (Technetium-99m, Iodine, Thallium-201 and others) and PET (Rubidium-82, Fluorine-18, and others)), by Application (cardiology, lymphoma, thyroid, neurology, oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 126 | Pages: 144 | December 2016 | Region: Asia Pacific


The Asia-Pacific nuclear medicine diagnostic market is estimated at $1.57 billion in 2015 and is poised to reach $3.01 billion by 2020, at a CAGR of 13.9%. Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most of the cases, the information helps to assist the physicians to make a quick and accurate diagnosis of the patient's illness.

SPECT imaging is the most conventional modality for nuclear medicine applications such as nuclear cardiology procedures. However, the trend is soon going to see a down turn owing to the shortage of molybdenum-99 isotope which in turn will lead to deficiency of Technetium-99, which is the by-product of molybdenum. Therefore, PET imaging products include hybrid PET-CT scanners are anticipated to account for a potentially hefty market share in the near future.

The emerging market tendency will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness fastest growth compared to SPECT imaging as it delivers higher resolution images and the technetium-99m is forcing industry to look for alternative diagnostic procedures

Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are some of the factors fuelling the growth of the market.However, shorter half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are acting as hurdles for the nuclear medicine market growth.

The Nuclear Medicine Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application,the market is categorized into SPECT (lymphoma, cardiology,neurology,thyroid and others) and PET(cardiology,oncology, neurology and others).

Furthermore, on the basis of geography, the market is divided into India, China, Japan and South Korea.

Some of the key players influencing the Asia-Pacific nuclear medicine market are Cardinal Health, Inc., Bracco Imaging S.p.A,GE Healthcare,Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc.,Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 By Type                                                        

                                5.1.1 SPECT                                        

                                                5.1.1.1 Technetium-99m                              

                                                5.1.1.2 Thallium-201                       

                                                5.1.1.3 Gallium-67                           

                                                5.1.1.4 Iodine-23                             

                                                5.1.1.5 Others                   

                                5.1.2 PET                                             

                                                5.1.2.1 Fluorine-18                          

                                                5.1.2.2 Rubidium-82                       

                                                5.1.2.3 Others                   

                5.2 By Application                                                           

                                5.2.1 Cardiology                                               

                                5.2.2 Lymphoma                                              

                                5.2.3 Thyroid                                     

                                5.2.4 Neurology                                               

                                5.2.5 Oncology                                 

                                5.2.6 Others                                      

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GE Healthcare                                                           

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Cardinal Health Inc.                                                 

                8.3 Bracco Imaging S.p.A                                                              

                8.4 Eczacibasi-Monrol Nuclear Products                                                

                8.5 Nordion, Inc.                                                              

                8.6 Bayer Healthcare                                                     

                8.7 Lantheus Medical Imaging, Inc.                                                          

                8.8 Advanced Accelerator Applications S.A.                                                         

                8.9 IBA Molecular Imaging                                                           

                8.10 Mallinckrodt plc.                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Nuclear Medicine Diagnostics Market By Region, From 2015-2020 (USD Billion)
  2. Asia-Pacific Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  3. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  4. Asia-Pacific PET Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  5. Asia-Pacific Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  6. Asia-Pacific Cardiology Market By Region, From 2015-2020 (USD Billion)
  7. Asia-Pacific Lymphoma Market By Region, From 2015-2020 (USD Billion)
  8. Asia-Pacific Thyroid Market By Region, From 2015-2020 (USD Billion)
  9. Asia-Pacific Neurology Market By Region, From 2015-2020 (USD Billion)
  10. Asia-Pacific Oncology Market By Region, From 2015-2020 (USD Billion)
  11. Asia-Pacific Other Applications Market By Region, From 2015-2020 (USD Billion)
  12. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  13. Asia-Pacific Technetium-99m Market By Region, From 2015-2020 ( USD Billion )
  14. Asia-Pacific Thallium-201 Market By Region, From 2015-2020 ( USD Billion )
  15. Asia-Pacific Gallium-67 Market By Region, From 2015-2020 ( USD Billion )
  16. Asia-Pacific Iodine-23 Market By Region, From 2015-2020 ( USD Billion )
  17. Asia-Pacific Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  18. Asia-Pacific PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  19. Asia-Pacific Fluorine-18 Market By Region, From 2015-2020 ( USD Billion )
  20. Asia-Pacific Rubidium-82 Market By Region, From 2015-2020 ( USD Billion )
  21. Asia-Pacific Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  22. China Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  23. China Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  24. India Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  25. India Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  26. Japan Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  27. Japan Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  28. South Korea Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  29. South Korea Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  30. China SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  31. India SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  32. Japan SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  33. South Korea SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  34. China PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  35. India PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  36. Japan PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  37. South Korea PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
Middle East And Africa Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU,...
Latin America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Asia Pacific Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Th...
Europe Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermogr...
North America Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast T...
Breast Imaging Market By Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, O...
Middle East And Africa High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (T...
Latin America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
Asia Pacific High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Iden...
Europe High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identifica...
North America High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Ide...
High Throughput Screening Market By Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Ultra-High-Throughput Screening, Label-Free Technology, Bioinformatics), Application (Target Identification, P...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.